Advertisement

Topics

Latest Biological Patent NewsRSS

06:25 EST 20th February 2017 | BioPortfolio

Divided Infringement - Expanding Patent Infringement Liability

In 2015, the Federal Circuit Court of Appeals cast the net of patent infringement liability even more broadly, to cover direct infringement by "divided" infringement. Akamai Technologies, Inc. v.

Week in Review: February 13?17

CRISPR patent decision; DNA database errors; science marches around the globe; more

Gene editing patent ruling sways fortune of biotech hopefuls

In a highly anticipated decision that could sway the fortunes of a handful of biotechnology companies, the federal patent office has turned back a challenge to patents covering a widely used method for editing genes. The office's board of appeals ruled Wednesday that the Broad Institute of MIT and Harvard can keep patents it had been awarded for a technique called CRISPR that lets scientists a...

Bay Area's Align Tech Claims Win in ClearCorrect Patent Spat

  Life Sciences Jobs   ...

Exclusive CRISPR licenses slow development of therapies, legal experts argue

Exclusive licenses granted to three for-profit companies on CRISPR genome-editing technology threaten to slow therapies, patent experts say.

CRISPR Patent Battle Determined on 2/15/2017 – USPTO issues a verdict in legal tussle over rights to genome-editing technology

CRISPR Patent Battle Determined on 2/15/2017 – USPTO issues a verdict in legal tussle over rights to genome-editing technology Curator: Aviva Lev-Ari, PhD, RN Broad Institute prevails in heated dispute over CRISPR patents Sharon Begley sharon.begley@statnews.com @sxbegle In a one-sentence judgment by the Patent Trial and Appeal Board, the three judges decided that there is “no […]

STAT Plus: Pharma trade group urges US trade rep to take action against Colombia

The industry trade group argued that Colombia should be given added scrutiny for purportedly failing to sufficiently protect and enforce patent rights.

MiMedx Announces Release Date for 2016 Full Year Results

MARIETTA, Ga., Feb. 16, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that its results for the fourth q...

#news #biotech Editas stock jumps after Broad wins CRISPR patent fight

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Editas stock jumps after Broad wins CRISPR patent fight .Editas stock jumps after Broad wins CRISPR patent fight nick.paul.taylor Thu, 02/16/2017 – 03:41 from Feed http://ift.tt/2ktGPli Cet article #news #biotech Editas stock jumps after Broad wins CRISPR patent fight es...

Zhang vs. Doudna patent ruling: Broad Institute holds patents but University of California may appeal

The US patent office ruled [Feb. 15] that hotly disputed patents on the revolutionary genome-editing technology CRISPR-Cas9 belong to the Broad Institute of Harvard and MIT, dealing a blow to the University of California in its ef

Symbiotix Biotherapies Announces Issuance of First Composition of Matter Patent Covering a Microbiome-derived Therapeutic Molecule

BOSTON–(BUSINESS WIRE)–#Biotherapies–Symbiotix Biotherapies, Inc. (“Symbiotix”), a pioneering microbiome company developing novel molecular therapeutics based on the human microbiome, today announced that the United States Patent and Trademark Office (USPTO) has granted U.S. Patent 9,539,281, “Lipid-containing PSA compositions, methods of isolation … Continue reading ...

The Patent Office has Spoken: What does it Mean for CRISPR in Europe?

The US Patent Office has ruled that the Broad Institute’s CRISPR patents do not interfere with those from UC Berkeley. While this might sound like everybody wins, it’s actually a loss for Charpentier and the CRISPR Therapeutics team. CRISPR has ... This awesome article The Patent Office has Spoken: What does it Mean for CRISPR in Europe? appeared first on Labiotech.eu. Be kind and don't co...

The CRISPR patent decision: Your six takeaways

The Broad Institute's win in its fight over key patents on CRISPR genome editing technology leaves many questions. We answer them.

STAT Plus: And the CRISPR science prizes go to…

In case you haven’t heard enough about Wednesday’s CRISPR patent ruling, we decided to tally up the winners in another court: the world of scientific prizes. Turns out, it’s not…

Spectro Scientific Wins U.S. Patent For Water Contamination Measurement Method Used In Its FluidScan Handheld Infrared Oil Analyzer

  Life Sciences Jobs   ...

Akers Biosciences Allowed US Patent For Akers Wellness Tests Cartridge

  Life Sciences Jobs   ...

The Winners And Losers In The CRISPR Patent Fight

  Life Sciences Jobs   ...

CRISPR, Intellia, Caribou Biosciences And ERS Genomics Provide Update On CRISPR/Cas9 U.S. Patent Interference Proceedings And Grants Of Corresponding Patents In The U.K.

  Life Sciences Jobs   ...

Spectro Scientific Wins U.S. Patent For Water Contamination Measurement Method Used In Its FluidScan Handheld Infrared Oil Analyzer

  Life Sciences Jobs   ...

An irreverant guide to winners and losers in the CRISPR patent fight

The Broad Institute won a bitter patent fight over the revolutionary gene-editing technology CRISPR. But it's not the only winner. Here's a scorecard.

An irreverent guide to winners and losers in the CRISPR patent fight

The Broad Institute won a bitter patent fight over the revolutionary gene-editing technology CRISPR. But it's not the only winner. Here's a scorecard.

Broad Institute prevails in heated dispute over CRISPR patents

The US patent office ruled Wednesday that hotly disputed patents on the revolutionary genome-editing technology CRISPR-Cas9 belong to the Broad Institute.

Patent Office Hands Win in CRISPR Battle to Broad Institute

The dispute between researchers at UC Berkeley and the Broad Institute over the invention of the powerful gene-editing technique has been decided.

Broad Wins CRISPR Patent Interference Case

The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

Broad Institute notches win in CRISPR patent battle

The ruling dealt a setback to the University of California and sent share prices of several CRISPR biotechs spinning. But future patent judgments could complicate the matter further.

Quick Search
Advertisement
 

review and buy Biological Patent market research data and corporate reports here